Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

A New View

Creating value is key to the future of marketing

Deal Watch November 2016

Actelion, Allergan, Johnson & Johnson, Novartis and more feature in this month's pharma deals round-up

- PMLiVE

McCann Health expands EMEA creative teams

Appoints directors at its Dubai, Germany and UK agencies

Google backs Indian mobile online doctor community

Curofy wins support from the firm's Launchpad Accelerator programme

- PMLiVE

Dr Martine Dehlinger-Kremer becomes EUCROF president

She brings experience from SynteractHCR

How can the NHS deliver integrated care?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, explain the changes needed to help the NHS provide a more holistic, joined up experience for patients

Wilmington Healthcare

Novartis building

Novartis adds oral eczema drug with Ziarco acquisition

Expands dermatology pipeline with first-in-class, Pfizer-developed treatment prospect

Eli Lilly HQ

Lilly nears EU approval of arthritis drug baricitinib

On course for early 2017 verdict, setting up challenge to Pfizer’s Xeljanz

- PMLiVE

Making a list and checking it twice…

The promise of mobile health lies not in recording information but in promoting behaviour change

- PMLiVE

Asceneuron appoints chief medical officer

Novartis’ Michael Ryan joins the neurodegenerative diseases specialist

Former Astellas regulatory lead joins Oxular

Robert Waters becomes regulatory affairs VP

Roche Basel Switzerland

Genentech names Anderson new CEO as Ian Clark retires

Leadership changes come as the Roche subsidiary faces increasing biologics competition

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links